RCC2 Expression Stimulates ER-Positive Breast Tumorigenesis.
Weiqi WangBing XuZhaoxu ZhangKehua FangXiaotian ChangPublished in: Journal of oncology (2020)
Our results suggest that estrogen-induced RCC2 expression prompts IGF1, TWIST1, and IL-6 expression, stimulates cell migration, and inhibits apoptosis to contribute to ER + breast tumorigenesis.